Mar 21, 2026HormonesTRT Heart Safety: TRAVERSE Reassures, Clot Risk RemainsTRAVERSE found no increase in major cardiac events with TRT, but rising neutrophils, monocytes, and hematocrit may identify clot risk.testosteronetrttraverse trialcardiovascular safetyRead article →